BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 28, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
July 24, 2013
View Archived Issues
Agreements/contracts: Group of 23 Georgia hospitals form alliance
Read More
Washington roundup: FDA says Prodigy Diabetes distributed failing test strips
Read More
International report: DaVita acquires dialysis operations in Malaysia
Read More
HIT roundup: CHI chooses Conifer's value-based care services
Read More
Financings roundup: Skylight Healthcare receives $10M loan from GE Capital
Read More
Deals roundup: Mediware in plan to acquire Definitive Homecare Solutions
Read More
Patent watch: VeriTeQ files provisional patent for a temp-resistant microchip
Read More
Grants roundup: Canis Lupus awards technology grant to Southern Illinois Univ.
Read More
People in the News
Read More
Product Briefs
Read More
Med-Tech News
Read More
MDD's Oncology Extra
Read More
Ivantis reveals HYDRUS II study results for glaucoma
Even though Ivantis' (Irvine, California) Hydrus Microstent has yet to gain FDA approval, word of the device is growing, and the company is developing a body of strong clinical results surrounding the technology.
Read More
Boston Scientific trial to use Precision for chronic migraine
Read More
